Filing metadata

Accession number
0001209191-23-046514
Form type
Form 4
Filer
BridgeBio Pharma, Inc.
CIK
CIK 1743881
Filed
Aug 18, 2023
Reporting period
Aug 16, 2023
Description
Insider transaction

Explore SEC Filings Hub